• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $ATEC

    Alphatec Holdings Inc.

    Subscribe to $ATEC
    $ATEC
    Medical/Dental Instruments
    Health Care

    Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; squadron lateral retractor designed to maximize patient outcomes; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System designed to improve surgical efficiency without compromising accuracy. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; solanas posterior cervico/thoracic fixation system and avalon occipital plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. Further, it develops EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is based in Carlsbad, California.

    IPO Year: 2006

    Exchange: NASDAQ

    Website: atecspine.com

    Peers

    $SPNE
    $SRGA
    $GMED

    Recent Analyst Ratings for Alphatec Holdings Inc.

    DatePrice TargetRatingAnalyst
    6/16/2025$18.00Buy
    Lake Street
    8/1/2024Overweight → Equal-Weight
    Morgan Stanley
    7/8/2024$19.00Overweight
    Barclays
    2/9/2024$26.00Overweight
    Wells Fargo
    12/19/2023$16.00 → $18.00Buy
    Needham
    10/20/2023$22.00Buy
    ROTH MKM
    10/12/2022$12.00Buy
    Jefferies
    9/12/2022$13.00Overweight
    Morgan Stanley
    3/2/2022$22.00 → $17.00Overweight
    Piper Sandler
    12/3/2021$12.50Neutral
    Goldman Sachs
    See more ratings

    Alphatec Holdings Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CHIEF OPERATING OFFICER Lish Scott sold $251,588 worth of shares (22,727 units at $11.07), decreasing direct ownership by 3% to 748,918 units (SEC Form 4)

      4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

      6/17/25 6:00:06 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Director Woods Ward W Jr was granted 15,131 shares, increasing direct ownership by 11% to 154,291 units (SEC Form 4)

      4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

      6/13/25 5:30:17 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Director Valentine Keith was granted 15,131 shares, increasing direct ownership by 18% to 97,271 units (SEC Form 4)

      4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

      6/13/25 5:30:16 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Director Rydin Jeffrey P was granted 15,131 shares, increasing direct ownership by 3% to 585,441 units (SEC Form 4)

      4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

      6/13/25 5:30:12 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Director Mcginnis Karen K was granted 15,131 shares and sold $47,992 worth of shares (3,963 units at $12.11), increasing direct ownership by 19% to 68,709 units (SEC Form 4)

      4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

      6/13/25 5:30:18 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Director Berkowitz Mortimer Iii was granted 15,131 shares, increasing direct ownership by 2% to 680,550 units (SEC Form 4)

      4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

      6/13/25 5:30:05 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Director Pelizzon David R was granted 15,131 shares, increasing direct ownership by 5% to 346,827 units (SEC Form 4)

      4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

      6/13/25 5:30:10 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Director Blackford Quentin S. was granted 15,131 shares, increasing direct ownership by 3% to 568,369 units (SEC Form 4)

      4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

      6/13/25 5:30:07 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Director Demski David M was granted 15,131 shares, increasing direct ownership by 4% to 429,623 units (SEC Form 4)

      4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

      6/13/25 5:30:09 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • EVP, PEOPLE & CULTURE Hunsaker Craig E sold $2,468,278 worth of shares (200,000 units at $12.34), decreasing direct ownership by 12% to 1,450,018 units (SEC Form 4)

      4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

      6/6/25 6:30:06 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care

    Alphatec Holdings Inc. SEC Filings

    See more
    • SEC Form S-8 filed by Alphatec Holdings Inc.

      S-8 - Alphatec Holdings, Inc. (0001350653) (Filer)

      6/13/25 4:46:41 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Alphatec Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Alphatec Holdings, Inc. (0001350653) (Filer)

      6/13/25 4:03:07 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • SEC Form 144 filed by Alphatec Holdings Inc.

      144 - Alphatec Holdings, Inc. (0001350653) (Subject)

      6/11/25 11:15:31 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • SEC Form 144 filed by Alphatec Holdings Inc.

      144 - Alphatec Holdings, Inc. (0001350653) (Subject)

      6/3/25 4:29:12 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • SEC Form SD filed by Alphatec Holdings Inc.

      SD - Alphatec Holdings, Inc. (0001350653) (Filer)

      5/28/25 5:09:39 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • SEC Form DEFA14A filed by Alphatec Holdings Inc.

      DEFA14A - Alphatec Holdings, Inc. (0001350653) (Filer)

      5/8/25 4:21:16 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • SEC Form 10-Q filed by Alphatec Holdings Inc.

      10-Q - Alphatec Holdings, Inc. (0001350653) (Filer)

      5/1/25 4:57:14 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Alphatec Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Alphatec Holdings, Inc. (0001350653) (Filer)

      5/1/25 4:17:29 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • SEC Form DEFA14A filed by Alphatec Holdings Inc.

      DEFA14A - Alphatec Holdings, Inc. (0001350653) (Filer)

      4/25/25 4:16:51 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • SEC Form DEF 14A filed by Alphatec Holdings Inc.

      DEF 14A - Alphatec Holdings, Inc. (0001350653) (Filer)

      4/25/25 4:14:39 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care

    Alphatec Holdings Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Bakst Evan bought $201,600 worth of shares (35,000 units at $5.76) (SEC Form 4)

      4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

      8/26/24 4:32:07 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Director Pelizzon David R bought $149,998 worth of shares (25,796 units at $5.81), increasing direct ownership by 8% to 331,696 units (SEC Form 4)

      4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

      8/26/24 4:27:25 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Director Demski David M bought $283,500 worth of shares (50,000 units at $5.67), increasing direct ownership by 21% to 288,441 units (SEC Form 4)

      4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

      8/21/24 10:00:00 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Director Demski David M bought $262,400 worth of shares (40,000 units at $6.56), increasing direct ownership by 20% to 238,441 units (SEC Form 4)

      4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

      8/5/24 2:49:29 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Director Valentine Keith bought $255,450 worth of shares (39,000 units at $6.55), increasing direct ownership by 90% to 82,140 units (SEC Form 4)

      4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

      8/5/24 2:48:20 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Bakst Evan bought $202,950 worth of shares (15,000 units at $13.53) (SEC Form 4)

      4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

      3/18/24 11:35:17 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Blackford Quentin S. bought $256,600 worth of shares (20,000 units at $12.83), increasing direct ownership by 4% to 572,605 units (SEC Form 4)

      4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

      3/8/24 8:55:59 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Demski David M bought $315,000 worth of shares (30,000 units at $10.50), increasing direct ownership by 20% to 181,694 units (SEC Form 4)

      4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

      11/13/23 10:19:03 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care

    Alphatec Holdings Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lake Street resumed coverage on Alphatec with a new price target

      Lake Street resumed coverage of Alphatec with a rating of Buy and set a new price target of $18.00

      6/16/25 8:53:19 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Alphatec downgraded by Morgan Stanley

      Morgan Stanley downgraded Alphatec from Overweight to Equal-Weight

      8/1/24 3:06:35 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Barclays initiated coverage on Alphatec with a new price target

      Barclays initiated coverage of Alphatec with a rating of Overweight and set a new price target of $19.00

      7/8/24 7:34:11 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Wells Fargo initiated coverage on Alphatec with a new price target

      Wells Fargo initiated coverage of Alphatec with a rating of Overweight and set a new price target of $26.00

      2/9/24 7:03:17 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Needham reiterated coverage on Alphatec with a new price target

      Needham reiterated coverage of Alphatec with a rating of Buy and set a new price target of $18.00 from $16.00 previously

      12/19/23 7:03:35 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ROTH MKM initiated coverage on Alphatec with a new price target

      ROTH MKM initiated coverage of Alphatec with a rating of Buy and set a new price target of $22.00

      10/20/23 7:48:42 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Jefferies initiated coverage on Alphatec with a new price target

      Jefferies initiated coverage of Alphatec with a rating of Buy and set a new price target of $12.00

      10/12/22 8:49:42 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Morgan Stanley initiated coverage on Alphatec with a new price target

      Morgan Stanley initiated coverage of Alphatec with a rating of Overweight and set a new price target of $13.00

      9/12/22 7:19:53 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Piper Sandler reiterated coverage on Alphatec Holdings with a new price target

      Piper Sandler reiterated coverage of Alphatec Holdings with a rating of Overweight and set a new price target of $17.00 from $22.00 previously

      3/2/22 6:23:30 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Goldman Sachs initiated coverage on Alphatec Holdings with a new price target

      Goldman Sachs initiated coverage of Alphatec Holdings with a rating of Neutral and set a new price target of $12.50

      12/3/21 5:30:29 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care

    Alphatec Holdings Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • iRhythm Technologies Announces Board Member Retirements and New Director Appointments

      SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) , a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the retirement of two long-serving board members, Mark Rubash and Ralph Snyderman, M.D., effective July 7, 2025. Concurrently, Karen McGinnis and Kevin O'Boyle have accepted appointments to the board of directors. Mark Rubash has served on the board since 2016, prior to the company's initial public offering, bringing decades of experience in finance, accounting, and strategy at high-growth technology companies. Ralph Snyderman, M.D., who joined the board in 2017, br

      7/7/25 8:30:00 AM ET
      $ABSI
      $ATEC
      $ILMN
      $IRTC
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
      Medical/Dental Instruments
      Medical Specialities
    • ATEC Reports First Quarter 2025 Financial Results and Raises Full-Year Guidance

      Surgical revenue grew 24%; total revenue grew 22% Full-year revenue and profitability guidance increased Successfully refinanced convertible debt to 2030 maturity Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended March 31, 2025, and recent corporate highlights. First Quarter 2025 Financial Results   Quarter Ended March 31, 2025 Total revenue $169 million GAAP gross margin 69% Non-GAAP gross margin 70% GAAP operating expenses $160 million Non-GAAP operating expenses $124 million GAAP net income /

      5/1/25 4:05:00 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC Launches PTP™ Corpectomy, The Next Evolution of Lateral Approach Surgery

      Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the commercial launch of its Prone TransPsoas (PTP™) Corpectomy system. This milestone marks the continued evolution of ATEC's PTP surgical approach, expanding its capabilities to include deformity and corpectomy procedures for complex pathologies of the thoracolumbar spine. "PTP Corpectomy represents a significant step forward in ATEC's commitment to improving patient outcomes in the most complex spine surgeries," said Pat Miles, Chairman and Chief Executive Officer. "By integrating advanced surgical techniques within a fully proceduralized

      4/21/25 9:00:00 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC to Report First Quarter 2025 Financial Results on May 1, 2025

      Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter 2025 financial results on May 1, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-In To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months. Inducemen

      4/14/25 9:00:00 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC Prices Upsized $350.0 Million Convertible Senior Notes Offering

      Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the pricing of its offering of $350,000,000 aggregate principal amount of 0.75% convertible senior notes due 2030 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The offering size was increased from the previously announced offering size of $300,000,000 aggregate principal amount of notes. The issuance and sale of the notes are scheduled to settle on March 7, 2025, subject to customary closing conditions. ATEC also granted the initi

      3/4/25 10:54:00 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC Announces Proposed Convertible Senior Notes Offering

      Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced its intention to offer, subject to market and other conditions, $300,000,000 aggregate principal amount of convertible senior notes due 2030 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). ATEC also expects to grant the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $50,000,000 principal amount of notes.

      3/3/25 4:00:00 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC Reports Fourth Quarter and Full Year 2024 Financial Results

      Full year 2024 total revenue grew 27% to $612 million, enabling significant profit margin expansion Full year 2025 total revenue expected to approximate $732 million and fuel free cash flow Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter and year ended December 31, 2024, and business highlights. Fourth Quarter and Full Year 2024 Financial Results Quarter Ended December 31, 2024 Year Ended December 31, 2024 Total revenue $177 million $612 million GAAP gross margin 69% 69% Non-GAAP gross marg

      2/26/25 4:00:00 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC to Participate in Upcoming Conferences

      Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences: The Canaccord Genuity Musculoskeletal Conference in San Diego, CA, on March 10 2025, with a fireside chat at 10:30am PT The Barclays Global Healthcare Conference in Miami, FL, on March 11, 2025, with a fireside chat at 3:00pm ET If available, the live webcasts will be accessible on ATEC's Investor Relations website. Inducement Awards Granted As an inducement material to accepting employment with the Company, and in accordance with Nasdaq Listing Rule 5635(c)(4

      2/24/25 9:00:00 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC Announces Select Preliminary Financial Results for 2024 and Provides 2025 Outlook

      Full-year 2024 total revenue grew 27% to approximately $611 million Expect full-year 2025 total revenue of $732 million and positive free cash flow Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary financial results for the fourth quarter and full-year ended December 31, 2024. The Company also provided a financial outlook for full-year 2025. Preliminary, Unaudited Fourth Quarter and Full-Year 2024 Revenue Ranges   Fourth Quarter Ended December 31, 2024 Full-Year Ended December 31, 2024 Surgical Revenue $155.6M to $156.6M $54

      1/13/25 9:00:00 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • Paragon 28 Appoints Dave Demski to Board of Directors

      Paragon 28, Inc. (NYSE:FNA), (the "Company") a leader in foot and ankle surgical solutions, today announced the appointment of Dave Demski to serve as an independent director of the Company, effective immediately. Mr. Demski brings a wealth of global orthopedic expertise, with over two decades of executive leadership experience. With the addition of Mr. Demski, the Company increased the size of its Board of Directors from eight members to nine members and has further strengthened its strategic oversight and governance capabilities. Mr. Demski most recently served as the President and CEO of Globus Medical from August 2017 to April 2022, guiding the organization through a period of signifi

      12/11/24 9:00:00 AM ET
      $ATEC
      $FNA
      Medical/Dental Instruments
      Health Care

    Alphatec Holdings Inc. Leadership Updates

    Live Leadership Updates

    See more
    • Paragon 28 Appoints Dave Demski to Board of Directors

      Paragon 28, Inc. (NYSE:FNA), (the "Company") a leader in foot and ankle surgical solutions, today announced the appointment of Dave Demski to serve as an independent director of the Company, effective immediately. Mr. Demski brings a wealth of global orthopedic expertise, with over two decades of executive leadership experience. With the addition of Mr. Demski, the Company increased the size of its Board of Directors from eight members to nine members and has further strengthened its strategic oversight and governance capabilities. Mr. Demski most recently served as the President and CEO of Globus Medical from August 2017 to April 2022, guiding the organization through a period of signifi

      12/11/24 9:00:00 AM ET
      $ATEC
      $FNA
      Medical/Dental Instruments
      Health Care
    • Spineology® Appoints new Member to Leadership Team; Spine Veteran Emory Rooney joins as Executive Vice President of Sales

      Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today the addition of Emory Rooney as Executive Vice President, Sales. In this role, Rooney will lead U.S. market growth and sales efforts. Rooney comes to Spineology with extensive spine sales experience, having served in Medical Device fields related to spinal implants and navigation for nearly 20 years. "The addition of Emory adds even further conviction about our clear opportunity for growth at Spineology," said Brian Snider, Chief Executive Officer at Spineology. "I have had the opportunity to work with Emory and have seen his impact leading sales teams, building new terri

      4/4/24 9:05:00 AM ET
      $ATEC
      $SYK
      Medical/Dental Instruments
      Health Care
    • John Booth to Retire as CEO of Spineology Inc.

      Brian Snider Appointed New CEO Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today that John Booth will retire from his role as Chief Executive Officer of Spineology, effective November 10, 2023. The Board of Directors has selected Brian Snider as its next Chief Executive Officer, effective November 13, 2023. Mr. Booth will remain with Spineology through 2024, serving in an advisory role to facilitate a smooth transition. Mr. Booth will also resign from the Board of Directors, and the Board has nominated Mr. Snider as a Director. Snider joins Spineology with nearly twenty years of progressive leadership experience in the

      11/9/23 9:00:00 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC to Preview the Informatics Sophistication of EOS Catalyst™ at NASS 2023

      Enhances EOS platform with automated alignment, surgical planning, patient-specific rod-bending, and intra-operative alignment reconciliation capabilities Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that EOS Catalyst will be introduced at the 2023 NASS Annual Meeting. EOS Catalyst builds on the already unprecedented functionality of the EOS imaging platform with automated alignment and surgical planning capabilities. "EOS is foundational to ATEC's mission to revolutionize spine surgery," said Pat Miles, Chairman and Chief Executive Officer. "Catalyst will be the first reflection of

      10/17/23 9:00:00 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC Advances Lateral Surgery With Launch of Expandable Technology

      Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that the Company's commitment to advancing lateral surgery will be prominent at the 2023 NASS Annual Meeting. The Company will introduce the Calibrate LTXTM lateral expandable implant system, technology designed to better achieve alignment goals with precise lordosis control and disc height restoration. "ATEC is uniquely dedicated to improving lateral surgery," said Pat Miles, Chairman and Chief Executive Officer. "The release of Calibrate LTX elevates our lateral procedural thesis by better enabling surgeons to achieve the most elusive goal

      10/16/23 4:05:00 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC Announces Preliminary Third Quarter 2023 Revenue Results and Raises Full-Year Revenue Guidance

      Total revenue of $117.7 to $118.5 million Total revenue growth of 31% to 32% Full-year 2023 total revenue now expected to approximate $472 million Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today select preliminary financial results for the third quarter ended September 30, 2023, and updated full-year 2023 revenue guidance ahead of investor meetings scheduled during the 2023 North American Spine Society (NASS) Annual Meeting. Preliminary Third Quarter 2023 Revenue Ranges   Quarter Ended September 30, 2023 Surgical Revenue $103.3M to $103.9M EOS Revenue

      10/16/23 9:00:00 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC Clinical Precision and Predictability on Display at NASS 2023

      Unleashing 100% spine focus to set the standard in spine care Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that the Company will feature technology designed to advance its comprehensive procedural solutions at the North American Spine Society (NASS) 38th Annual Meeting, which will be held at the Los Angeles Convention Center in California from October 18 to 21, 2023. "While others in our industry grapple with distraction, ATEC's presence at NASS 2023 will clearly demonstrate how 100% spine focus brings an unparalleled ability to revolutionize spine surgery," said Pat Miles, Chairman

      10/9/23 4:05:00 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC Appoints Beth Altman to Board of Directors

      CARLSBAD, Calif., July 26, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that Beth Altman, former Managing Partner at KPMG LLP San Diego, has been appointed as an independent director to the ATEC Board of Directors ("Board") and as Chair of the Audit Committee of the Board, with both appointments to be effective as of August 12, 2021. The Company also announced the resignation of Donald A. Williams as an independent director and as Chair of the Audit Committee of the Board and member of its Finance Committee, with such resignations effective as of August 11, 2021

      7/26/21 4:05:00 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC Appoints Marie Meynadier, Ph.D., to Board of Directors

      CARLSBAD, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that Marie Meynadier, Ph.D., founder of EOS imaging, has been appointed as an independent director to the ATEC Board. With over 25 years of experience in the high tech and medical device industries, Dr. Meynadier currently sits on boards of multiple medical technology companies in Europe and North America. She founded and served as Chief Executive Officer of EOS imaging until 2018, after which she remains a director and head of the Strategic Committee. Prior to her tenure at EOS, Dr. Meynad

      6/21/21 4:30:00 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC Announces Preliminary First Quarter 2021 Revenue Results and Provides Corporate Updates

      First quarter 2021 U.S. revenue grows approximately 50% compared to last year Full year 2021 U.S. revenue growth now expected to exceed 30% Tender offer for EOS imaging cleared by French regulatory authority J. Todd Koning appointed Chief Financial Officer CARLSBAD, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary revenue results for the first quarter ended March 31, 2021. The Company confirmed that the Autorité des marchés financiers (AMF), France’s financial markets regulator, cleared ATEC’s public tender offer f

      4/8/21 9:05:00 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care

    Alphatec Holdings Inc. Financials

    Live finance-specific insights

    See more
    • ATEC to Report First Quarter 2025 Financial Results on May 1, 2025

      Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter 2025 financial results on May 1, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-In To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months. Inducemen

      4/14/25 9:00:00 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC to Report Third Quarter Financial Results on October 30, 2024

      Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report third quarter 2024 financial results on October 30, 2024, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months. Indu

      10/7/24 9:00:00 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC to Report Second Quarter Financial Results on July 31, 2024

      Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2024 financial results on July 31, 2024, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months.

      7/10/24 9:00:00 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC to Report First Quarter Financial Results on May 7, 2024

      Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter 2024 financial results on May 7, 2024, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months. In

      4/17/24 9:00:00 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC to Report Second Quarter Financial Results on August 3, 2023

      Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2023 financial results on August 3, 2023, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months.

      7/18/23 9:00:00 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC Acquires Navigation-Enabled Robotics Platform; Raises 2023 Revenue Guidance on Strength of Preliminary First Quarter Revenue Results

      REMI Robotic Navigation System to advance ATEC's procedural strategy by integrating navigation and robotics into spine workflow First quarter 2023 total revenue expected to grow more than 52% to over $108 million Full-year total revenue guidance raised to $450 million Reaffirms break-even adjusted EBITDA in 2023 and break-even free cash flow in 2025 Webcast today at 2:00pm PT/ 5:00pm ET Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it has acquired all assets related to the REMI Robotic Navigation System from Fusion Robotics, LLC, a privately held medical technology co

      4/19/23 4:05:00 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC to Report First Quarter 2023 Financial Results on May 4, 2023

      Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter financial results on May 4, 2023, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months. In additi

      4/13/23 9:00:00 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 28, 2023

      Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report fourth quarter and fiscal year 2022 financial results on February 28, 2023, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for tw

      2/7/23 9:00:00 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC to Report Second Quarter 2022 Financial Results on August 4, 2022

      Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2022 financial results on August 4, 2022, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months. In additi

      7/21/22 9:00:00 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • ATEC to Report First Quarter 2022 Financial Results on May 5, 2022

      Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter 2022 financial results on May 5, 2022, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial in to the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months

      4/21/22 9:00:00 AM ET
      $ATEC
      Medical/Dental Instruments
      Health Care

    Alphatec Holdings Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Alphatec Holdings Inc.

      SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

      11/12/24 8:04:57 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13D/A filed by Alphatec Holdings Inc. (Amendment)

      SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

      3/22/24 7:57:56 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13D/A filed by Alphatec Holdings Inc. (Amendment)

      SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

      5/12/23 4:51:18 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13D/A filed by Alphatec Holdings Inc. (Amendment)

      SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

      6/28/22 9:36:02 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13D filed

      SC 13D - Alphatec Holdings, Inc. (0001350653) (Subject)

      3/11/21 4:21:54 PM ET
      $ATEC
      Medical/Dental Instruments
      Health Care